- Home
- BLMZ vs RDHL Comparison
BLMZ vs RDHL Comparison
Compare BLMZ & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLMZ
- RDHL
- Stock Information
- Founded
- BLMZ 2017
- RDHL 2009
- Country
- BLMZ Japan
- RDHL Israel
- Employees
- BLMZ N/A
- RDHL N/A
- Industry
- BLMZ
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- BLMZ
- RDHL Health Care
- Exchange
- BLMZ NYSE
- RDHL Nasdaq
- Market Cap
- BLMZ 8.7M
- RDHL 8.6M
- IPO Year
- BLMZ 2024
- RDHL N/A
- Fundamental
- Price
- BLMZ $0.49
- RDHL $6.99
- Analyst Decision
- BLMZ
- RDHL
- Analyst Count
- BLMZ 0
- RDHL 0
- Target Price
- BLMZ N/A
- RDHL N/A
- AVG Volume (30 Days)
- BLMZ 155.2K
- RDHL 21.2K
- Earning Date
- BLMZ 12-24-2024
- RDHL 12-27-2024
- Dividend Yield
- BLMZ N/A
- RDHL N/A
- EPS Growth
- BLMZ N/A
- RDHL N/A
- EPS
- BLMZ N/A
- RDHL N/A
- Revenue
- BLMZ $1,246,643.00
- RDHL $3,707,000.00
- Revenue This Year
- BLMZ N/A
- RDHL $224.90
- Revenue Next Year
- BLMZ N/A
- RDHL $82.69
- P/E Ratio
- BLMZ N/A
- RDHL N/A
- Revenue Growth
- BLMZ 29.63
- RDHL N/A
- 52 Week Low
- BLMZ $0.48
- RDHL $6.35
- 52 Week High
- BLMZ $4.30
- RDHL $43.50
- Technical
- Relative Strength Index (RSI)
- BLMZ N/A
- RDHL 42.91
- Support Level
- BLMZ N/A
- RDHL $7.09
- Resistance Level
- BLMZ N/A
- RDHL $7.44
- Average True Range (ATR)
- BLMZ 0.00
- RDHL 0.53
- MACD
- BLMZ 0.00
- RDHL -0.03
- Stochastic Oscillator
- BLMZ 0.00
- RDHL 12.36
About BLMZ BLOOMZ INC
BloomZ Inc operates as an audio-producing and voice actor managing company. The company provides audio production services and voice-acting educational services in Japan. The business lines of the company are the audio production business, the VTuber management business, and the voice actor workshop business. The audio production comprises producing audios for animations and video games using dubbing, BGM producing, and mixing techniques; the Vtuber management business creates motion-capture technology for streamers to provide the voice to stream real-time videos featuring human facial expressions and gestures; and the voice actor workshop provides practical voice acting services.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.